Royalty Pharma: welcome clarity mixed with unwelcome ambiguity

At the end of April the Court of Justice of the European Union (CJEU) delivered its judgment in Case C-650/17 Royalty Pharma Collection Trust.

Already registered?

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk

More on this story

Americas

Will the EU’s SPC manufacturing waiver weaken European pharma’s IP?

20 May 2020 Despite dire warnings by the US Chamber of Commerce, the impact of the EU’s SPC waiver won’t be known for years, says Paul Williams of Lewis Silkin.

Europe

Unitary SPC should follow new patent system: EC official

11 June 2020 The European Commission wants to implement a unitary supplementary protection certificate, its top IP official has said.

Big Pharma

UKIPO cancels SPC extension at owner’s request

16 June 2020 The UK Intellectual Property Office has agreed to revoke an extension to a supplementary protection certificate for immunosuppressant tocilizumab, at the request of the owners.

More on this story

Americas

Will the EU’s SPC manufacturing waiver weaken European pharma’s IP?

20 May 2020 Despite dire warnings by the US Chamber of Commerce, the impact of the EU’s SPC waiver won’t be known for years, says Paul Williams of Lewis Silkin.

Europe

Unitary SPC should follow new patent system: EC official

11 June 2020 The European Commission wants to implement a unitary supplementary protection certificate, its top IP official has said.

Big Pharma

UKIPO cancels SPC extension at owner’s request

16 June 2020 The UK Intellectual Property Office has agreed to revoke an extension to a supplementary protection certificate for immunosuppressant tocilizumab, at the request of the owners.

More on this story

Americas

Will the EU’s SPC manufacturing waiver weaken European pharma’s IP?

20 May 2020 Despite dire warnings by the US Chamber of Commerce, the impact of the EU’s SPC waiver won’t be known for years, says Paul Williams of Lewis Silkin.

Europe

Unitary SPC should follow new patent system: EC official

11 June 2020 The European Commission wants to implement a unitary supplementary protection certificate, its top IP official has said.

Big Pharma

UKIPO cancels SPC extension at owner’s request

16 June 2020 The UK Intellectual Property Office has agreed to revoke an extension to a supplementary protection certificate for immunosuppressant tocilizumab, at the request of the owners.

More features

Fed Circ orders Teva to delist five patents from Orange Book

Novartis shields eye-drop patent at European Patent Office

CREATES Act unfairly tips the scales to generics

LSPN launches its first-ever US awards to celebrate life sciences leaders

Pharma giants seek closure on COVID-19 vaccine rows

Foley & Lardner adds litigation and transaction expert in New York

‘AI curious’ counsel at AZ, Novartis weigh risks and benefits

Trump’s return sparks calls for pro-patent agenda

Royalty Pharma: welcome clarity mixed with unwelcome ambiguity

More on this story

Editor's picks

Editor's picks

More on this story

More on this story

More features